This inventor holds 2 USPTO granted patents. Top assignees: Barros Research Institute, Michigan State University. Active years: 2008-2012.
Company Filing History:
Years Active: 2008-2012
Title: David Juckett: Innovator in Immunotherapy
Introduction
David Juckett is a notable inventor based in East Lansing, MI (US). He has made significant contributions to the field of immunotherapy, particularly in the prevention and treatment of cancer and infectious diseases. With a total of 2 patents, his work focuses on innovative methods that stimulate immune responses in subjects.
Latest Patents
David Juckett's latest patents include compositions and methods for immunotherapy of cancer and infectious diseases. These inventions provide compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases. They aim to stimulate an immune response in a subject and serve as alternatives to interleukin-12 (IL-12) treatment. Specifically, his inventions involve Apicomplexa-related proteins (ARPs) that exhibit immune stimulatory activity, making them valuable in the treatment and prevention of cancer and infectious diseases, as well as in immune modulation.
Career Highlights
Throughout his career, David Juckett has worked with esteemed organizations such as the Barros Research Institute and Michigan State University. His experience in these institutions has allowed him to develop and refine his innovative approaches to immunotherapy.
Collaborations
David has collaborated with notable colleagues, including Charles Aylsworth and Siu-Cheong Ho. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
David Juckett's contributions to immunotherapy highlight his dedication to advancing medical science. His innovative patents and collaborations reflect his commitment to improving treatment options for cancer and infectious diseases.